loading
Regulatory Affairs Training in the USA

Regulatory Affairs Training in the USA

Comprehensive online regulatory training aligned with FDA regulations, 21 CFR, and ICH standards — trusted by US pharmaceutical, biotech, and generic drug professionals. Self-paced. 21 CFR Part 11 compliant certificates. Inspection-ready training records for FDA audits.

10+ modules
Regulatory Affairs Courses
21 CFR
Part 11 Compliant Certs
Regulatory Affairs
Regulatory Affairs
FDA & ICH
Aligned
Regulatory Context

Regulatory Compliance in the USA: FDA, 21 CFR & ICH Standards

The U.S. Food and Drug Administration (FDA) enforces one of the most stringent and complex regulatory frameworks in the world for pharmaceuticals and biologics. The framework is built upon the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act, with implementing regulations codified in Title 21 of the Code of Federal Regulations (21 CFR). US regulatory professionals must master the requirements for the full drug development lifecycle, including INDs, NDAs, BLAs, and ANDAs, all while adhering to ICH guidelines for global harmonization.

Agency/Standard Framework Application
FDA Federal Food, Drug, and Cosmetic Act Statutory authority for drug regulation
FDA 21 CFR Parts 200-499, 600-699 Regulations for drugs, biologics, and devices
FDA 21 CFR Part 312 Investigational New Drug Application regulations
FDA 21 CFR Part 314 New Drug Application regulations
FDA 21 CFR Part 601 Biologics License Application regulations
ICH ICH Guidelines (E, M, Q, S series) International harmonisation for submissions
The U.S. Food and Drug Administration (FDA) enforces one of the most stringent and complex regulatory frameworks in the world for pharmaceuticals and biologics.
Our Courses

Regulatory Affairs Training Courses — FDA & ICH Aligned

All courses are self-paced, available online, and include 21 CFR Part 11 compliant certificates with verifiable IDs — accepted as documented training records during FDA inspections.

For Distributors, Wholesalers & Logistics Teams
Biologics License Application (BLA) Certification Program
Health Canada GDP, WHO GDP guidelines, EK GDP guidelines
$499.00 per person
10 modules Self-paced Certificate included

Provides comprehensive knowledge of the planning, preparation, submission, and review of BLAs to the FDA. The program covers the full eCTD structure, CMC, nonclinical and clinical data, FDA review processes, and inspection readiness. This is essential for the booming US biotech sector.

Enroll in Biologics License Application
For Distributors, Wholesalers & Logistics Teams
Mastering the NDA
Health Canada GDP, WHO GDP guidelines, UK GDP guidelines
$499.00 per person
10 modules Self-paced Certificate included

Covers the entire drug development and approval process, with a deep dive into each component of the New Drug Application (NDA) organized into the five CTD modules. This program is foundational for any professional in the US pharmaceutical industry involved in innovative drug development.

Enroll in Mastering the NDA
For Canadian Manufacturers Supplying the USA Market
Mastering the Orphan Drug NDA
Parts I & II, Annex 1 (revised 2022), Annex 11, Annex 15
$499.00 per person
10modules Self-paced Certificate included

Covers the entire orphan drug development and approval process under the Orphan Drug Act of 1983. Participants learn the step-by-step process for obtaining orphan drug designation from the FDA Office of Orphan Products Development, including benefits like seven-year exclusivity and tax credits.

Enroll in Mastering the Orphan Drug NDA
For Distributors, Wholesalers & Logistics Teams
The Investigational New Drug (IND) Framework
Health Canada GDP, WHO GDP guidelines, EU GDP guidelines
$499.00 per person
12+modules Self-paced Certificate included

Provides a comprehensive end-to-end understanding of the IND framework as regulated by the FDA. This program covers the legal basis for the IND exemption, the detailed preparation of the initial IND package, the 30-day review timeline, and safety monitoring. It is critical for anyone involved in initiating clinical trials in the US.

Enroll in Regulatory Affairs Specialists
For Canadian Manufacturers Supplying the USA Market
Certified Regulatory Affairs Professional (CRAP)
Parts I & II, Annex 1 (revised 2022), Annex 11, Annex 15
$799.00 per person
10modules Self-paced Certificate included

Comprehensive certification covering the global pharmaceutical regulatory landscape with a strong focus on the US FDA and ICH requirements. This program provides foundational and advanced strategic capabilities across all major application types (IND, NDA, ANDA, BLA).

Enroll in Regulatory Affairs Training
Who Needs Training

Who Needs Regulatory Training in the USA?

Regulatory training is mandatory for all professionals involved in the research, development, manufacturing, and marketing of FDA-regulated products.

Warehousing & Storage
  • Warehouse managers, supervisors, and operators
  • Cold chain and temperature monitoring specialists
  • Inventory and stock rotation personnel
  • Returns and quarantine handlers
Transportation & Distribution
  • Transport managers and fleet supervisors
  • Logistics coordinators and dispatchers
  • Drivers handling temperature controlled deliveries
  • Shipping and receiving staff
Quality & Compliance
  • Quality Assurance (QA) managers and officers
  • GDP compliance officers
  • Internal auditors
  • Responsible Persons (RPs) and deputies
  • Regulatory Affairs (RA) managers
Contract Services
  • Third party logistics (3PL) providers
  • Contract warehouse operators
  • Distribution service providers
  • Importers and exporters of pharmaceutical products
Health Canada Inspections

GDP Inspections, Compliance Risk & Training Records

What Happens When GDP Training Falls Short

The FDA conducts inspections of pharmaceutical manufacturers, distributors, and logistics providers. Inspection findings can have serious consequences:

  • Warning Letters — FDA warning letters are published publicly and can damage reputation
  • Import Alerts — Products may be detained at the border
  • Consent Decrees — Court-enforced agreements with significant oversight costs
  • Product Recalls — Costly and damaging to brand trust
  • Criminal Prosecution — In cases of deliberate non-compliance

Common FDA GDP inspection observations include:

  • Inadequate temperature monitoring and control
  • Poor training records and undocumented training
  • Insufficient excursion investigations
  • Lack of written agreements with contract acceptors
  • Inadequate supply chain security measures (DSCSA compliance)
Inspection Ready Training Records

Our 21 CFR Part 11 compliant certificates provide auditable, documented training records that FDA investigators accept during inspections.

Unique verifiable certificate ID — check at gxptrainings.com/verify-certificate/
Includes completion date, course name, and assessment score
Downloadable PDF — upload to any QMS or LMS
Accepted by FDA inspectors
Satisfies FDA 21 CFR Part 211.25 (personnel qualifications) and GDP training requirements
Canada's PIC/S Membership

Canada’s Membership in PIC/S — Why It Matters for Your GDP Training

Canada joined the Pharmaceutical Inspection Co operation Scheme (PIC/S) — the international body that harmonises GMP and GDP standards across 55 member countries. This has direct implications for how GDP training is structured for Canadian professionals.

Health Canada Aligned with EU GDP

Health Canada GDP requirements are closely aligned with EU GDP and WHO GDP — meaning training that covers PIC/S harmonised GDP principles is relevant for Canadian professionals working in any international context.

International Recognition

Canadian facilities with Health Canada GDP certification are recognised by many international regulators. Our training covers the core GDP principles recognised by all PIC/S member authorities — including FDA, EMA, and WHO.

Multi Market Compliance

Canadian distributors supplying the US, EU, or other markets must meet multiple regulatory frameworks simultaneously. Our GDP courses cover all relevant frameworks in a single, comprehensive program.

Corporate Training for Canadian Logistics Companies

Training your entire QA, warehouse, or transport team? We offer group enrollment for Canadian pharmaceutical logistics companies of all sizes. Group quotes provided within 24 hours.

Corporate Training Packages
Why GxP Trainings

Why Choose GxP Trainings for GDP Auditor Certification

Feature GxP Trainings
FDA 21 CFR Part 205 aligned
FDA 21 CFR Parts 210 & 211 aligned
DSCSA requirements covered
DSCSA requirements covered
PIC/S GDP Guide (PE 011 1) covered
WHO GDP aligned
ICH Q9 (Quality Risk Management) covered
21 CFR Part 11 compliant certificate
Self paced — study on your schedule
Instant certificate download
Verifiable certificate ID
Group / corporate enrollment
FAQs

Frequently Asked Questions

Q Is online regulatory training accepted by the FDA?

The FDA does not pre-approve training providers but expects that personnel are adequately trained. Our 21 CFR Part 11 compliant certificates provide verifiable, auditable proof of training that is widely accepted during FDA inspections.

Q What is the record retention requirement for FDA submissions?

Under 21 CFR Part 314 and 312, records must be retained for specific periods, often for 2 years after approval or for the duration of the investigation. Our certificates provide permanent, traceable records.

Q Do you offer group discounts for US companies?

Yes. We offer corporate and group enrollment options for teams of all sizes. Contact us for a custom quote.

Q How long do I have access to the course?

All courses include lifetime access — study at your own pace, on your own schedule.

Q Are the certificates verifiable?

Yes. Each certificate includes a unique verifiable ID that can be checked at gxptrainings.com/verify-certificate/

Start Your Regulatory Affairs Training Today

Equip yourself and your team with the Regulatory Affairs knowledge and documented training records required for Health Canada, FDA, and WHO inspection readiness.

10 modules Self-paced Health Canada, FDA & WHO aligned 21 CFR Part 11 compliant certificate $799
Enroll in Regulatory Affairs — $799